Bococizumab is a cutting-edge anti-PCSK9 antibody effectively developed to treat hypercholesterolemia. This therapeutic agent works by the PCSK9 protein, a essential regulator of cholesterol concentrations. By https://socialmediainuk.com/story26386137/bococizumab-a-novel-anti-pcsk9-antibody-for-hypercholesterolemia